Date Initiated by Firm | July 14, 2005 |
Date Posted | August 23, 2005 |
Recall Status1 |
Terminated 3 on May 02, 2006 |
Recall Number | Z-1384-05 |
Recall Event ID |
32711 |
Product Classification |
Aid, Surgical, Viscoelastic - Product Code LZP
|
Product | Amvisc Sodium Hyaluronate 0.5 mL. Bausch & Lomb, Inc., Rochester, NY
Product Number: 59051 |
Code Information |
Lot Numbers: CO50510A, C050510 |
Recalling Firm/ Manufacturer |
Anika Therapeutics, Inc. 236 W Cummings Park Woburn MA 01801-6346
|
For Additional Information Contact | Tim Mayhew 781-932-6616 Ext. 142 |
Manufacturer Reason for Recall | Product sterility may be compromised due incomplete heat seals in the cannula pouches that are included with the viscoelastic syringe. |
FDA Determined Cause 2 | Other |
Action | Anika Therapeutics notified Distributor accounts by telephone on July 14. The letters were faxed and sent by Fedex on July 14. Distributors were provided with a end-user letter template letter for notification to their accounts. |
Quantity in Commerce | 5799 |
Distribution | CA, NC |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|